Health Care · Pharmaceutical Preparations · OTC · CIK 1510964 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.02Day +0.00%Mkt cap $4M1Y −50.0%Off 52W high −80.0%Vol (1Y) 226.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 3,126 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Sales (TTM)$13.4M |
| Earnings (TTM)-$1.5M |
| ROE−58.7% |
| Net margin−6.9% |
| Debt / equity1.12× |
| Sales growth 3Y−5.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−66.7% |
| 1Y−50.0% |
| 3Y−60.0% |
| 5Y−93.5% |
| 10Y−94.5% |
| Since incept. (ann.)−20.0% |
Price return through 2026-07-28 · series begins 2011-11-09. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)226.2% |
| Ann. volatility (3Y)200.9% |
| Sharpe (1Y)0.64 |
| Sharpe (3Y)0.78 |
| Max drawdown (1Y)−80.0% |
| Max drawdown (3Y)−81.5% |
| Beta (3Y vs SPY)0.98 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for CVSI.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | $0.00 | — | $3.2M | −11.4% |
| 2025-12-31 | 2026-03-26 | — | — | $3.3M | −14.9% |
| 2025-09-30 | 2025-11-13 | $0.00 | — | $3.3M | −15.8% |
| 2025-06-30 | 2025-08-13 | $0.00 | — | $3.6M | −8.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
